Evidence map›Paper›PMID 18815309›Full record

ArticleJournal of virology2008

Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.

Shadi Salloum, Cesar Oniangue-Ndza, Christoph Neumann-Haefelin, Laura Hudson, Silvia Giugliano, Marc aus dem Siepen, Jacob Nattermann, Ulrich Spengler, Georg M Lauer, Manfred Wiese and 7 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. CD8Frontiers in immunology · 2022
    Article
  3. A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis.Journal of clinical and translational hepatology · 2021
    Review
  4. Review
  5. Adaptive Immune Response against Hepatitis C Virus.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Shadi SalloumUniversity of Essen, Department of Virology, Virchowstrasse 179, 45147 Essen, Germany.
Cesar Oniangue-Ndza
Christoph Neumann-Haefelin
Laura Hudson
Silvia Giugliano
Marc aus dem Siepen
Jacob Nattermann
Ulrich Spengler
Georg M Lauer
Manfred Wiese
Paul Klenerman
Helen Bright
Norbert Scherbaum
Robert Thimme
Michael Roggendorf
Sergei Viazov
Joerg Timm
University of Duisburg-Essen · DEGlaxoSmithKline (United Kingdom) · GBUniversity of Bonn · DEUniversity of Freiburg · DEJohn Radcliffe Hospital · GBKlinikum St. Georg · DEMassachusetts General Hospital · US

Funding

The role of NK cells during acute HCV infection and antiviral therapyU19AI066345 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KIM, ARTHUR Y · 2005 to 2014
$8.5M
NIAID NIH HHS U19 AI066345Wellcome Trust
6 · The paper itself

Abstract

The inherent sequence diversity of the hepatitis C virus (HCV) represents a major hurdle for the adaptive immune system to control viral replication. Mutational escape within targeted CD8 epitopes during acute HCV infection has been well documented and is one possible mechanism for T-cell failure. HLA-B*08 was recently identified as one HLA class I allele associated with spontaneous clearance of HCV replication. Selection of escape mutations in the immunodominant HLA-B*08-restricted epitope HSKKKCDEL(1395-1403) was observed during acute infection. However, little is known about the impact of escape mutations in this epitope on viral replication capacity. Their previously reported reversion back toward the consensus residue in patients who do not possess the B*08 allele suggests that the consensus sequence in this epitope is advantageous for viral replication in the absence of immune pressure. The aim of this study was to determine the impact of mutational escape from this immunodominant epitope on viral replication. We analyzed it with a patient cohort with chronic HCV genotype 1b infection and in a single-source outbreak (genotype 1b). Sequence changes in this highly conserved region are rare and selected almost exclusively in the presence of the HLA-B*08 allele. When tested in the subgenomic replicon (Con1), the observed mutations reduce viral replication compared with the prototype sequence. The results provide direct evidence that escape mutations in this epitope are associated with fitness costs and that the antiviral effect of HLA-B*08-restricted T cells is sufficiently strong to force the virus to adopt a relatively unfavorable sequence.

Indexed as

AllelesCD8-Positive T-LymphocytesDEAD-box RNA HelicasesEpitopes, T-LymphocyteGenotypeHepacivirusHLA-B AntigensHumansImmunodominant EpitopesMutationNucleoside-TriphosphataseSerine EndopeptidasesViral Nonstructural ProteinsViral ProteasesVirus ReplicationDEAD-box RNA HelicasesEpitopes, T-LymphocyteHLA-B AntigensImmunodominant EpitopesNS3 protein, hepatitis C virusNucleoside-TriphosphataseSerine EndopeptidasesViral Nonstructural ProteinsViral Proteases

Identifiers

PMID18815309
PMCPMC2583685
OpenAlexW2142415747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.